| (Values in U.S. Thousands) | Dec, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
| Sales | 107,880 | 90,050 | 70,190 | 37,050 | 22,240 |
| Sales Growth | +19.80% | +28.29% | +89.45% | +66.59% | +20.48% |
| Net Income | -33,520 | -38,070 | -43,100 | -44,040 | -29,000 |
| Net Income Growth | +11.95% | +11.67% | +2.13% | -51.86% | -1.19% |
Medx Health Corp (MDXHF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Mdxhealth is a commercial-stage precision diagnostics company which provides actionable molecular information to personalize patient diagnosis and treatment. The Company's tests are based on proprietary genomic, epigenetic and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. Mdxhealth, formerly known as MDxHealth SA, is based in IRVINE, CA.
Fiscal Year End Date: 12/31